Gyre Therapeutics, Inc. (GYRE) vs MiMedx Group, Inc (MDXG)
- Gyre Therapeutics, Inc. GYRE 6.08 −5.00%
- MiMedx Group, Inc MDXG 4.43 −5.34%
Gyre Therapeutics, Inc. and MiMedx Group, Inc are both Biotechnology companies. Gyre Therapeutics, Inc. and MiMedx Group, Inc are of similar size ($682.2M and $678.6M). Gyre Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 111×. Gyre Therapeutics, Inc. grew revenue faster over the last twelve months: 10.7% against −2.36%. MiMedx Group, Inc has the higher net margin (1.76% vs −13.7%) and the higher return on invested capital (5.62% vs −8.51%). Across the 18 metrics below, MiMedx Group, Inc leads on 13 and Gyre Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | GYRE | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.15% | 78.85% | 65.16% |
| Operating margin | (10.53%) | 2.46% | 0.00% |
| Net margin | (13.73%) | 1.76% | 0.00% |
| Free cash flow margin | (6.12%) | 12.51% | 0.00% |
| Return on equity | (11.75%) | 2.88% | (56.36%) |
| Return on assets | (9.08%) | 2.18% | (48.04%) |
| Return on invested capital | (8.51%) | 5.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack